Upharmacia June 2017
O rganizations can be C anceled
Parliamentary Committee on
Public Health approved the
Draft Law to cancel public
procurements of drugs through
international organizations.
In 2015, Ukrainian government
started cooperation with
international organizations
(UNDR, UNICEF and Crown
Agents) within the delegated
public procurement of drugs
and medical devices. The
cooperation allowed saving
considerable funds and
counteracting corruption
mechanisms. However, a
lot of experts complained
at the inefficiency of such
procurements due to delayed
supplies and short expiration
dates.
CIS REGION PHARMA
NEWS
B elarus
Borisov Medicines Plant
(Borimed) is looking for investor
to establish the production of substances
in Belarus. Currently, the company is
implementing large-scale reconstruction of
ampoule production to launch three GMP
production sites by the year-end.
— —
R ussia
Russian Group of
companies R-Pharm transferred
the rights for its innovative molecule (an-
tibody-biosimilar of cetuximab) to the US
company Aspyrian. The molecule is now in the
II phase of clinical trials.
— —
— — The government of St. Petersburg and
BIOCAD company signed the agreement on
the realization of investment projects on
production biological substances. The project
is aimed to attract investments in the amount
of more than RUB 3 bn.
— — Indian pharmaceutical concern Cadila will
invest USD 50 mio in the manufacturing
located in the Moscow region.
— — In May the number of pharmacies in
Russia reached 61 ths. Thus, the number of
pharmacies increased 6% vs May 2015.
— — Pharmaceutical Plant of St. Petersburg is
looking for acquirer or investor to continue
launching new products onto the market.
— — Novosibirsk biotech park opened the
biggest in the Asian part of Russia center
for certification of drugs, food supplements
and cosmetics. The center expects to start
self-financing since 2018.
— — The government of Kaliningrad region, South
Korean company NEPES and Russian company
Infamed K signed the Memorandum on
intention to establish the manufacturing of
urological catheters in the region.
www.upharma-c.com
9